贝康医疗-B(02170)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02170 贝康医疗-B

未开盘 10-15 15:59:11

1.300

-0.020

-1.52%

最高1.300	最低1.260	成交量4.30万
今开1.280	昨收1.320	日振幅3.03%
总市值3.55亿	流通市值1.07亿	总股本2.73亿
成交额5.54万	换手率0.05%	流通股本8,268万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02170","market":"HK","secType":"STK","nameCN":"贝康医疗-B","latestPrice":1.3,"timestamp":1792051151516,"preClose":1.32,"halted":0,"volume":43000,"delay":0,"changeRate":-0.015151515151515164,"floatShares":82683799,"shares":273000000,"eps":-0.816942,"marketStatus":"未开盘","change":-0.02,"latestTime":"10-15 15:59:11","open":1.28,"high":1.3,"low":1.26,"amount":55445,"amplitude":0.030303,"askPrice":1.3,"askSize":36500,"bidPrice":1.26,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-0.734512,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792114200000},"marketStatusCode":0,"adr":0,"listingDate":1612713600000,"exchange":"SEHK","adjPreClose":1.32,"openAndCloseTimeList":[[1792027800000,1792036800000],[1792040400000,1792051200000]],"volumeRatio":0.9930715951389149,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02170","defaultTab":"news","newsList":[{"id":"2675837845","title":"贝康医疗-B(02170.HK)10月15日斥资4.91万港元回购3.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675837845","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675837845?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:15","pubTimestamp":1792059328,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1597","02170","BK1222","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193312412","title":"贝康医疗-B：2026年10月15日回购3.8万股，涉资约4.91万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193312412","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193312412?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:11","pubTimestamp":1792059106,"startTime":"0","endTime":"0","summary":"10月15日，苏州贝康医疗股份有限公司公告显示，公司于2026年10月15日在香港联交所场内回购普通股H股3.8万股，约占此前已发行股本的0.046%。回购价格介乎每股1.28港元至1.30港元，总金额约4.91万港元。公告同时指出，公司回购授权于2026年6月4日获股东大会通过，可回购股份总数为8,271,383股，至今已合共回购76,000股，占当日获授权股份数的约0.0919%。公司确认本次回购事宜已严格遵守香港联交所证券上市规则及相关法例。公告由执行董事梁波签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"贝康医疗-B：2026年10月15日回购3.8万股，涉资约4.91万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197123442","title":"贝康医疗-B回购4000股股份，总额约5200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197123442","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197123442?lang=zh_cn&edition=full","pubTime":"2026-10-14 18:21","pubTimestamp":1791973275,"startTime":"0","endTime":"0","summary":"苏州贝康医疗股份有限公司于2026年10月14日发布公告，当日于香港联交所回购H股普通股4000股，每股回购价为港币1.30元，涉资合计约港币5200元。该回购股份占公司现有已发行股本约0.0048%。本次回购完成后，公司已发行股本总数为82,713,835股，其中82,675,835股为已发行股份，库藏股数量增至38,000股。根据公告，购回股份后在2026年11月13日之前，公司不会进行新的股份发行或转让已回购的库藏股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"贝康医疗-B回购4000股股份，总额约5200港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675597853","title":"贝康医疗－Ｂ(02170.HK)10月13日耗资5200港元回购4000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675597853","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675597853?lang=zh_cn&edition=full","pubTime":"2026-10-13 19:47","pubTimestamp":1791892023,"startTime":"0","endTime":"0","summary":"格隆汇10月13日丨贝康医疗－Ｂ(02170.HK)公告，10月13日耗资5200港元回购4000股，每股回购价格1.3港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261013/32395650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1574","EWH","BK1222","02170","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189492383","title":"贝康医疗-B回购4,000股股份，总额5,200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189492383","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189492383?lang=zh_cn&edition=full","pubTime":"2026-10-13 19:25","pubTimestamp":1791890740,"startTime":"0","endTime":"0","summary":"贝康医疗-B于2026年10月13日发布公告称，公司于当日通过香港联交所场内回购4,000股H股，该回购股份约占此前公司已发行股本约0.0048%。每股回购价格为港币1.3元，总涉资约港币5,200元。公告显示，完成本次回购后，公司将遵循上市规则相关条文，在2026年11月12日之前暂停新股发行及库藏股再出售或转让。公司亦确认，本次股份回购已严格遵守香港联交所上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"贝康医疗-B回购4,000股股份，总额5,200港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157629377","title":"贝康医疗-B 10月12日回购1.50万股，涉资约1.94万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157629377","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157629377?lang=zh_cn&edition=full","pubTime":"2026-10-12 21:31","pubTimestamp":1791811907,"startTime":"0","endTime":"0","summary":"苏州贝康医疗股份有限公司于2026年10月12日发布翌日披露报表，宣布在香港联合交易所场内购回15,000股H股。本次回购数量占公司该次回购前现有已发行股份的约0.0181%。回购价格区间为每股港币1.28元至1.30元，合计支付约港币19,395元。本次回购完成后，公司于2026年10月12日的已发行股份总数仍为82,713,835股，其中已发行股份为82,683,835股，库存股份为30,000股。本公告由苏州贝康医疗股份有限公司执行董事梁波签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"贝康医疗-B 10月12日回购1.50万股，涉资约1.94万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674808471","title":"贝康医疗-B(02170.HK)10月12日斥资1.94万港元回购1.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674808471","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674808471?lang=zh_cn&edition=full","pubTime":"2026-10-12 21:23","pubTimestamp":1791811394,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1222","BK1574","BK1597","02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165496509","title":"贝康医疗-B：10月9日回购1.50万股，涉资约1.88万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165496509","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165496509?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:11","pubTimestamp":1791555117,"startTime":"0","endTime":"0","summary":"贝康医疗-B（股票代码：02170）于2026年10月9日发布公告，披露公司当日在香港联交所场内进行股份回购。\n本次回购数量为15,000股，约占公司当前已发行股本的0.0181%。回购价格介乎每股港币1.22至1.26港元，合计支付约1.88万港元。回购完成后，公司已发行股本约为82,698,835股，另持有库藏股15,000股。\n公司已于2026年6月4日通过本次回购授权，授权购回股份的总数为8,271,383股。截至目前，公司已在交易所购回股份15,000股。公司确认已遵守香港联交所证券上市规则及相关法律法规的规定。\n公告由执行董事梁波签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"贝康医疗-B：10月9日回购1.50万股，涉资约1.88万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674577148","title":"贝康医疗-B(02170)10月9日斥资1.88万港元回购1.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674577148","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674577148?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:07","pubTimestamp":1791554850,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B(02170)发布公告，于2026年10月9日斥资1.88万港元回购1.5万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1222","BK1597","02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134347796","title":"贝康医疗-B（02170）拟动用不超500万元回购最多827.14万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1134347796","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134347796?lang=zh_cn&edition=full","pubTime":"2026-10-09 18:52","pubTimestamp":1791543120,"startTime":"0","endTime":"0","summary":"贝康医疗-B10月9日发布自愿公告称，公司董事会拟根据2026年6月4日股东周年大会授予的一般无条件授权，在公开市场实施H股回购计划。授权允许公司回购的股份数量上限为截至2026年6月4日已发行H股总数的10%，即8,271,383股。公司表示，H股回购的实施将视市场状况而定，回购时间、数量及价格由董事会全权酌情决定，亦不保证一定会进行任何股份回购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674885598","title":"贝康医疗-B(02170)拟斥资不超过500万元购回H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674885598","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674885598?lang=zh_cn&edition=full","pubTime":"2026-10-09 18:42","pubTimestamp":1791542526,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B 发布公告，董事会欣然宣布，其拟根据购回授权行使其权力，且本公司将根据市场状况及购回授权的条款不时于公开市场购回H股，金额不超过人民币500万元。本公司拟以其自有财务资源而非香港联合交易所有限公司H股上市所得款项为股份购回计划提供资金。董事会认为， H股目前的交易价格低估了本公司的内在价值及业务前景，而股份购回计划将提升股东价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","BK1574","02170","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117592199","title":"贝康医疗-B2026年9月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1117592199","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117592199?lang=zh_cn&edition=full","pubTime":"2026-10-07 16:36","pubTimestamp":1791362171,"startTime":"0","endTime":"0","summary":"苏州贝康医疗股份有限公司于2026年10月7日发布了截至2026年9月30日的股份变动月报。报告显示，期内公司已发行股份及注册股本均未发生变动。截至2026年9月30日，公司股本结构保持稳定，已发行股份总数保持不变。公司同时确认已遵守香港联合交易所有限公司的相关上市规则和适用法律规定。本次月报由公司执行董事梁波签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135656215","title":"贝康医疗-B 2026年中期收入1.29亿元，净亏损72.0百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135656215","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135656215?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:17","pubTimestamp":1790241423,"startTime":"0","endTime":"0","summary":"截至2026年6月30日，贝康医疗-B录得收入1.29亿元，同比增长27.0%。期内录得净亏损72.0百万元，同比收窄约40.7%。毛利达到69.33百万元，同比上升30.3%，毛利率从上年同期的52.5%增长至53.8%。本期经营性亏损68.81百万元，销售及分销开支为49.0百万元，同比下降7.2%，行政开支48.6百万元，同比下降21.8%。报告期内，研发开支为32.7百万元，较去年同期下降42.4%。经营现金流方面，报告期经营活动现金净流出61.44百万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"贝康医疗-B 2026年中期收入1.29亿元，净亏损72.0百万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667400546","title":"贝康医疗-B(02170.HK)：GEMS系列玻璃化冷冻液及解冻液套装获国家药监局颁发三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2667400546","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667400546?lang=zh_cn&edition=full","pubTime":"2026-09-15 21:46","pubTimestamp":1789479966,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09996","BK1597","BK1222","02170","BK1574","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117355886","title":"苏州贝康医疗-B：Gems玻璃化冷冻及复苏套装获NMPA三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=1117355886","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117355886?lang=zh_cn&edition=full","pubTime":"2026-09-15 21:45","pubTimestamp":1789479939,"startTime":"0","endTime":"0","summary":"苏州贝康医疗-B宣布，其Gems玻璃化冷冻及复苏套装已正式获得国家药品监督管理局颁发的三类医疗器械注册证书。这一里程碑式的进展，标志着该公司在辅助生殖技术领域的又一次重要突破。据悉，此次获批的Gems系列产品，专为胚胎和卵子的冷冻保存及解冻复苏环节精心打造。未来，贝康医疗将持续深耕辅助生殖全产业链，力求以更具创新性的产品矩阵，满足多元化的临床需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170","BK1597","BK1222","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160278386","title":"贝康医疗-B获批两款GEMS系列玻璃化冷冻及解冻液套装三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=1160278386","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160278386?lang=zh_cn&edition=full","pubTime":"2026-09-15 21:45","pubTimestamp":1789479934,"startTime":"0","endTime":"0","summary":"2026年9月15日，贝康医疗-B发布自愿公告称，其GEMS系列玻璃化冷冻液套装及玻璃化解冻液套装已分别获得国家药品监督管理局颁发的三类医疗器械注册证，注册证号为国械注进20263180326及国械注进20263180338。截至公告日期，GEMS系列已获取卵液、精子洗涤液、受精培养液、卵裂胚培养液、囊胚培养液、胚胎培养液、胚胎处理液等多款核心试剂注册批准。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162628991","title":"贝康医疗8月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1162628991","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162628991?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:35","pubTimestamp":1788428159,"startTime":"0","endTime":"0","summary":"苏州贝康医疗股份有限公司于2026年9月3日发布了截至2026年8月31日的证券变动月报表。公告显示，报告期内公司整体股本结构无变化，具体情况如下：。截至2026年8月31日，公司法定/注册股本总额为人民币273,526,000元，较上月保持不变。公司表示在此期间及此前并未回购公司任何上市证券，并将持续遵守香港联交所《上市规则》及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662910850","title":"贝康医疗-B(02170)发布中期业绩 净亏损7204.8万元 同比收窄40.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662910850","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662910850?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:53","pubTimestamp":1787928794,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B(02170)发布截至2026年6月30日止6个月中期业绩，集团收入人民币1.29亿元，同比增长27.05%;净亏损7204.8万元，同比收窄40.7%;每股亏损0.26元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1597","02170","BK1222","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154397333","title":"贝康医疗-B2026年上半年营收1.29亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154397333","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154397333?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:37","pubTimestamp":1787924247,"startTime":"0","endTime":"0","summary":"截至2026年6月30日止六个月，贝康医疗-B实现营收约1.29亿元，同比增加27.0%。本期毛利约0.69亿元，同比提升30.3%。毛利率从上年同期的52.5%上升至53.8%，主要来自高毛利产品占比上升。销售及分销开支约0.49亿元，同比减少7.2%。行政开支约0.49亿元，同比下降21.8%。研发投入约0.33亿元，同比减少42.4%。在中国市场方面，收入同比增长35.1%。海外市场双轮驱动下，亚太地区收入同比增长88.1%，其中韩国、日本、泰国及越南等地需求强劲。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"贝康医疗-B2026年上半年营收1.29亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116875293","title":"贝康医疗-B（02170）将于8月28日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1116875293","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116875293?lang=zh_cn&edition=full","pubTime":"2026-08-18 18:10","pubTimestamp":1787047833,"startTime":"0","endTime":"0","summary":"贝康医疗-B（02170）8月18日公告，公司董事会计划于2026年8月28日（星期五）举行会议，主要议程包括：\n\\n\n\\n1. 审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩及其发布；\n\\n\n\\n2. 讨论并考虑建议派发中期股息（如有）。\n\\n\n\\n公告显示，董事会成员包括执行董事梁波博士、孔令印先生及姜雋超女士；非执行董事赵业先生及王伟鹏先生；独立非执行董事康熙雄博士、林兆荣先生及杨树标博士。\n\\n\n\\n公司董事长兼总经理梁波博士已签署本次董事会会议通告。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0484},{"period":"1month","weight":0.0039},{"period":"3month","weight":-0.0152},{"period":"6month","weight":-0.3434},{"period":"1year","weight":-0.5455},{"period":"ytd","weight":-0.3011}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":-0.0245},{"period":"3month","weight":-0.0203},{"period":"6month","weight":-0.0802},{"period":"1year","weight":-0.0713},{"period":"ytd","weight":-0.0612}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"苏州贝康医疗股份有限公司是一家主要提供辅助生殖基因检测解决方案的中国公司。该公司主要研发、生产及销售基因检测试剂盒、基因检测设备、仪器及消耗品。该公司主要产品包括胚胎植入前非整倍体基因检测（PGT-A）试剂盒、胚胎植入前单基因缺陷检测（PGT-M）试剂盒和样本保存液等遗传实验室产品、精子质量分析仪、家用精子检测设备和精子线粒体功能检测试剂盒等男科实验室产品、智能液氮罐和玻化冻存管等冷冻实验室、“Geri”全时差胚胎培养箱和“Gavi”全自动玻璃化冷冻仪等胚胎实验室产品、以及辅助生殖智能管理系统和PGT-A软件等软件产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.002951},{"month":2,"riseRate":0.6,"avgChangeRate":0.105265},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.100603},{"month":4,"riseRate":0.5,"avgChangeRate":0.007862},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.103247},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.024761},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.041153},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.045314},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.023231},{"month":10,"riseRate":0.5,"avgChangeRate":0.020595},{"month":11,"riseRate":0.2,"avgChangeRate":-0.017242},{"month":12,"riseRate":0.2,"avgChangeRate":-0.11073}],"exchange":"SEHK","name":"贝康医疗-B","nameEN":"BASECARE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"贝康医疗-B(02170)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供贝康医疗-B(02170)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"贝康医疗-B,02170,贝康医疗-B股票,贝康医疗-B股票老虎,贝康医疗-B股票老虎国际,贝康医疗-B行情,贝康医疗-B股票行情,贝康医疗-B股价,贝康医疗-B股市,贝康医疗-B股票价格,贝康医疗-B股票交易,贝康医疗-B股票购买,贝康医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"贝康医疗-B(02170)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供贝康医疗-B(02170)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}